72313-37-2Relevant articles and documents
Compound as protein degradation agent and preparation method and medical application thereof
-
, (2021/11/03)
The invention discloses a compound serving as a protein degrading agent and a preparation method and medical application thereof, and particularly discloses a compound represented by the formula (I) and a pharmaceutically acceptable salt thereof, and the
Synthesis and biological activity of a novel series of 6-substituted thieno[2,3-d]pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate transpo
Deng, Yijun,Zhou, Xilin,Desmoulin, Sita Kugel,Wu, Jianmei,Cherian, Christina,Hou, Zhanjun,Matherly, Larry H.,Gangjee, Aleem
experimental part, p. 2940 - 2951 (2010/02/28)
A series of seven 2-amino-4-oxo-6-substituted thieno[2,3-d]pyrimidines with bridge length variations (from 2 to 8 carbon atoms) were synthesized as selective folate receptor (FR) α and β substrates and as antitumor agents. The syntheses were accomplished
Prostaglandin isosteres. 2. Chain-modified thiazolidinone prostaglandin analogues as renal vasodilators
Bicking,Bock,Cragoe Jr.,DiPardo,Gould,Holtz,Lee,Robb,Smith,Springer,Blaine
, p. 342 - 348 (2007/10/02)
-
